MET-Dependent Activation of STAT3 as Mediator of Resistance to MEK Inhibitors in KRAS-Mutant Lung Cancer

Por: Lazzari, C, Karachaliou, N, Verlicchi, A, Servat, CC, Capitan, AG, Servat, JC, Bertran-Alamillo, J, Vila, MAM, Chaib, I, Serrano, JLR, Cao, P, De Marinis, F, Gregorc, V and Rosell, R

---

Publicada: 1 ene 2017

---

---

Filiaciones:
Lazzari, C:
 Ieo, Div Oncol Torac, Milan, Italy

Karachaliou, N:
 Hosp Univ Quiron Dexeus, Inst Oncol Dr Rosell IOR, Barcelona, Spain

Verlicchi, A:
 Osped Santa Maria Delle Croci, Oncol, Ravenna, Italy

Servat, CC:
 Pangaea Biotech Sl, Lab Cellular & Mol Biol, Ior Quiron Dexeus Univ Inst, Barcelona, Spain

Capitan, AG:
 Pangaea Biotech Sl, Lab Cellular & Mol Biol, Ior Quiron Dexeus Univ Inst, Barcelona, Spain

Servat, JC:
 Pangaea Biotech Sl, Lab Cellular & Mol Biol, Ior Quiron Dexeus Univ Inst, Barcelona, Spain

Bertran-Alamillo, J:
 Pangaea Biotech Sl, Lab Cellular & Mol Biol, Ior Quiron Dexeus Univ Inst, Barcelona, Spain

Vila, MAM:
 Pangaea Biotech Sl, Lab Cellular & Mol Biol, Ior Quiron Dexeus Univ Inst, Barcelona, Spain

:
 Inst Invest Ciencies Germans Trias & Pujol, Lab Cellular & Mol Biol, Badalona, Spain

:
 Catalan Inst Oncol, Lab Cellular & Mol Biol, Badalona, Spain

 Inst Invest Ciencies Germans Trias & Pujol, Badalona, Spain

Cao, P:
 Nanjing Univ Chinese Med, Hosp Integrated Tradit Chinese & Western Med, Lab Cellular & Mol Biol, Nanjing, Jiangsu, Peoples R China

De Marinis, F:
 European Inst Oncol, Div Thorac Oncol, Milan, Italy

Gregorc, V:
 Osped San Raffaele, IRCCS, Med Oncol, Milan, Italy

:
 Catalan Inst Oncol, Lab Cellular & Mol Biol, Badalona, Spain

 Inst Invest Ciencies Germans Trias & Pujol, Badalona, Spain